FRANK KARBE - 25 Apr 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Director
Signature
/s/ Larry Miller, Attorney-in-Fact for Frank Karbe
Issuer symbol
PHAT
Transactions as of
25 Apr 2022
Net transactions value
$0
Form type
4
Filing time
26 Apr 2022, 17:21:46 UTC
Previous filing
09 Jul 2021
Next filing
27 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHAT Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 25 Apr 2022 Common Stock 20,000 $13.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to one-third of the shares of common stock on April 25, 2023, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the reporting person's continuous service to the Issuer on the applicable vesting dates.